These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 401986)

  • 21. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.
    Lenaerts A; Codden T; Meunier JC; Henry JP; Ligny G
    Hepatology; 2006 Oct; 44(4):844-9. PubMed ID: 17006921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism.
    Radó JP; Marosi J; Takó J
    Endokrinologie; 1970; 57(1):46-62. PubMed ID: 4923990
    [No Abstract]   [Full Text] [Related]  

  • 23. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
    Lenaerts A; Codden T; Henry JP; Van Cauter J; Meunier JC; Ligny G
    Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The diuretic effect of demethylchlortetracycline in non-compensated hepatic cirrhosis].
    Ronchi E; Cattani F; Croce G; Magri F; Cappellini F; Rosati R; Lucchelli PD
    Recenti Prog Med; 1981 Apr; 70(4):418-32. PubMed ID: 6789413
    [No Abstract]   [Full Text] [Related]  

  • 25. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hyponatremia in a cirrhotic suffering from late cutaneous porphyria: a drug to avoid, demeclocycline].
    Boissonnas A; Casassus P; Caquet R; Laroche C
    Nouv Presse Med; 1979 Jan; 8(3):210. PubMed ID: 122011
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of diuretics in the treatment of cirrhotic ascites.
    Boyer TD; Warnock DG
    Gastroenterology; 1983 May; 84(5 Pt 1):1051-5. PubMed ID: 6832557
    [No Abstract]   [Full Text] [Related]  

  • 28. Hyponatremia of cirrhosis: role of vasopressin and decreased 'effective' plasma volume.
    Akriviadis EA; Ervin MG; Cominelli F; Fisher DA; Reynolds TB
    Scand J Gastroenterol; 1997 Aug; 32(8):829-34. PubMed ID: 9282977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prolonged treatment of ascitic cirrhosis by the combination of a saldiuretic and a spironolactone].
    Tolot F; Dechavannes M; Fiere D
    Lyon Med; 1966 Jan; 215(1):29-35. PubMed ID: 5904663
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experience in the treatment of water-salt retentions in cirrhosis by the antialdosterone 11614 R.P].
    Boivin P; Fauvert R
    Rev Int Hepatol; 1969; 19(4):241-51. PubMed ID: 5404532
    [No Abstract]   [Full Text] [Related]  

  • 31. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?
    Bansal S; Lindenfeld J; Schrier RW
    Circ Heart Fail; 2009 Jul; 2(4):370-6. PubMed ID: 19808361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-aldosterone therapy in cirrhosis of the liver with ascites].
    Loginov AS; Berezov VM
    Sov Med; 1967 Feb; 30(2):39-42. PubMed ID: 5597952
    [No Abstract]   [Full Text] [Related]  

  • 34. Prophylaxis of carbamazepine-induced hyponatremia by demeclocycline in six patients.
    Brewerton TD; Jackson CW
    J Clin Psychiatry; 1994 Jun; 55(6):249-51. PubMed ID: 8071279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study.
    Thuluvath PJ; Maheshwari A; Wong F; Yoo HW; Schrier RW; Parikh C; Steare S; Korula J
    Aliment Pharmacol Ther; 2006 Sep; 24(6):973-82. PubMed ID: 16948809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of hyponatremic cirrhosis with ascites resistant to diuretics by urea.
    Decaux G; Mols P; Cauchie P; Flamion B; Delwiche F
    Nephron; 1986; 44(4):337-43. PubMed ID: 3796773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human atrial natriuretic peptide (ANP) for the treatment of patients with liver cirrhosis and ascites.
    Brabant G; Jüppner H; Kirschner M; Böker K; Schmidt FW; Hesch RD
    Klin Wochenschr; 1986; 64 Suppl 6():108-11. PubMed ID: 2948056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of mastalgia with tamoxifen in male patients with liver cirrhosis: a randomized crossover study.
    Li CP; Lee FY; Hwang SJ; Chang FY; Lin HC; Kuo BI; Chu CJ; Lee SD
    Am J Gastroenterol; 2000 Apr; 95(4):1051-5. PubMed ID: 10763958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spironolactone and frusemide in cirrhosis with ascites.
    Sadikali F
    Br J Clin Pract; 1973 Jun; 27(6):222-4. PubMed ID: 4582147
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pathogenesis of hyponatremia observed in the treatment of acute subarachnoid hemorrhage].
    Kurokawa Y; Uede T; Honda O; Kato T
    No To Shinkei; 1992 Oct; 44(10):905-11. PubMed ID: 1285991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.